Panagora Asset Management Inc. reduced its stake in West Pharmaceutical Services, Inc., potentially impacting the stock price.
Stock AI’s forecasts:
🔴 -12.0% short-term ⬇️
🟢 +1.1% long-term ⬆️
Stock AI’s (WST) Forecast get (+6.0% Profit)
StockAI’s analysis delivers real-world results. On 08 February 2024, $WST ($412.84), StockAI predicted a long-term 🔴 sell signal. It was accurate: 1 month later price dropped to $387.9 (🔴-6.0%). Selling WST on this signal yielded a +6.0% profit 💰💰.
WST-West Pharmaceutical Services, Inc. News
🔴 Panagora Asset Management Inc. reduced its stake in West Pharmaceutical Services, Inc. by 15.4% during the 4th quarter.
🔴 Teacher Retirement System of Texas cut its stake in WST by 35.2% in the 4th quarter.
🟢 BNP Paribas Financial Markets boosted its holdings in shares of West Pharmaceutical Services, Inc. by 396.8% in the fourth quarter.
🟢 Commerce Bank increased its stake in WST by 6.3% during the fourth quarter.
🔴 Natixis Advisors L.P. lowered its stake in shares of West Pharmaceutical Services, Inc. by 6.8% during the 4th quarter.
🔴 Principal Financial Group Inc. reduced its holdings in WST by 22.8% in the fourth quarter.
The recent news surrounding West Pharmaceutical Services, Inc. stock has been a mix of positive and negative developments. While some institutions like BNP Paribas Financial Markets and Commerce Bank have increased their stake in the company, others such as Panagora Asset Management Inc. and Teacher Retirement System of Texas have reduced their holdings significantly. This mixed sentiment has led to uncertainty in the market regarding the future performance of WST stock.
The reduction in stakes by Panagora Asset Management Inc. and Teacher Retirement System of Texas may indicate a lack of confidence in West Pharmaceutical Services, Inc., potentially leading to a decrease in stock price in the short term. On the other hand, the increased holdings by BNP Paribas Financial Markets and Commerce Bank could signal positive growth prospects for the company, potentially leading to a slight increase in stock price in the long term.
Overall, the conflicting actions taken by different institutions regarding their stake in WST stock have created a sense of volatility in the market. Investors may want to closely monitor future developments and company performance to make informed decisions about their investment in West Pharmaceutical Services, Inc.
WST-West Pharmaceutical Services, Inc. Analyst Ratings
In recent analyst ratings for West Pharmaceutical Services, Inc. stock, there have been several changes noted:
📈 William Blair analysts lifted their Q3 2024 earnings per share estimates for shares of West Pharmaceutical Services.
📉 Zacks Research lowered their Q2 2024 earnings per share estimates for West Pharmaceutical Services.
📉 Zacks Research analysts lifted their Q4 2024 earnings estimates for West Pharmaceutical Services.
Sources:
1. ETF Daily News
2. ETF Daily News
3. ETF Daily News
Disclaimer
Investors may consider the AI predictions and news summaries as one factor in their investment decisions alongside their own research and risk tolerance.
Ready to analyze your own portfolio?
Get the same AI-powered insights for any stock you choose. It's easy!
